Introduction to Simulations And The Fda
Exploring Simulations And The Fda reveals several interesting facts. This webinar will discuss the benefits of using numerical
Simulations And The Fda Comprehensive Overview
Dr. Mark R. Gasronguay, Founder and CEO of the Metrum Research Group, discusses how to use Dr. Mark R. Gasronguay, Founder and CEO of the Metrum Research Group, asks “why use models?” when there's observed data, ... The
This GastroPlus™ User Group/
Summary & Highlights for Simulations And The Fda
- Eleftheria Tsakalozou, Satish Sharan, and Lanyan (Lucy) Fang discuss audience questions. Learn more at ...
- FDA
- Ross Walenga from the Office of Generic Drugs discusses (1) Current knowledge gap between regional deposition and systemic ...
- Leverage advanced modeling and
- Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses the role of modeling and
Stay tuned for more updates related to Simulations And The Fda.